98 related articles for article (PubMed ID: 20463065)
21. Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.
Guo Y; Dong L; Qiu X; Wang Y; Zhang B; Liu H; Yu Y; Zang Y; Yang M; Huang Z
Nature; 2014 Jan; 505(7482):229-33. PubMed ID: 24402281
[TBL] [Abstract][Full Text] [Related]
22. Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
Ai Y; Ma J
Biochem Biophys Res Commun; 2015 Feb; 457(3):385-90. PubMed ID: 25582776
[TBL] [Abstract][Full Text] [Related]
23. Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins.
Zhang J; Wu J; Wang W; Wu H; Yu B; Wang J; Lv M; Wang X; Zhang H; Kong W; Yu X
Retrovirology; 2014 Sep; 11():77. PubMed ID: 25213124
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.
Larue RS; Lengyel J; Jónsson SR; Andrésdóttir V; Harris RS
J Virol; 2010 Aug; 84(16):8193-201. PubMed ID: 20519393
[TBL] [Abstract][Full Text] [Related]
25. Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest.
Salamango DJ; Harris RS
Front Microbiol; 2020; 11():622012. PubMed ID: 33510734
[TBL] [Abstract][Full Text] [Related]
26. Is the tryptophan codon of gene vif the Achilles' heel of HIV-1?
Villanova F; Barreiros M; Leal É
PLoS One; 2020; 15(6):e0225563. PubMed ID: 32570272
[TBL] [Abstract][Full Text] [Related]
27. Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.
Azimi FC; Lee JE
Protein Sci; 2020 Feb; 29(2):391-406. PubMed ID: 31518043
[TBL] [Abstract][Full Text] [Related]
28. A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.
Bennett RP; Salter JD; Smith HC
Trends Mol Med; 2018 May; 24(5):507-520. PubMed ID: 29609878
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
30. An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation.
Bennett RP; Stewart RA; Hogan PA; Ptak RG; Mankowski MK; Hartman TL; Buckheit RW; Snyder BA; Salter JD; Morales GA; Smith HC
Antiviral Res; 2016 Dec; 136():51-59. PubMed ID: 27825797
[TBL] [Abstract][Full Text] [Related]
31. Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins.
Ly HJ; Ikegami T
Virol J; 2016 Jul; 13():118. PubMed ID: 27368371
[TBL] [Abstract][Full Text] [Related]
32. Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase.
Wang H; Lv G; Zhou X; Li Z; Liu X; Yu XF; Zhang W
BMC Microbiol; 2014 Nov; 14():290. PubMed ID: 25424878
[TBL] [Abstract][Full Text] [Related]
33. Structural insights for HIV-1 therapeutic strategies targeting Vif.
Salter JD; Morales GA; Smith HC
Trends Biochem Sci; 2014 Sep; 39(9):373-80. PubMed ID: 25124760
[TBL] [Abstract][Full Text] [Related]
34. Structural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloB.
da Costa KS; Leal E; dos Santos AM; Lima e Lima AH; Alves CN; Lameira J
PLoS One; 2014; 9(2):e89116. PubMed ID: 24586532
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3.
Evans SL; Schön A; Gao Q; Han X; Zhou X; Freire E; Yu XF
Retrovirology; 2014 Jan; 11():4. PubMed ID: 24422669
[TBL] [Abstract][Full Text] [Related]
36. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
[TBL] [Abstract][Full Text] [Related]
37. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.
Zhou X; Han X; Zhao K; Du J; Evans SL; Wang H; Li P; Zheng W; Rui Y; Kang J; Yu XF
J Virol; 2014 Mar; 88(5):2555-63. PubMed ID: 24352440
[TBL] [Abstract][Full Text] [Related]
38. Insight into the HIV-1 Vif SOCS-box-ElonginBC interaction.
Lu Z; Bergeron JR; Atkinson RA; Schaller T; Veselkov DA; Oregioni A; Yang Y; Matthews SJ; Malim MH; Sanderson MR
Open Biol; 2013 Nov; 3(11):130100. PubMed ID: 24225024
[TBL] [Abstract][Full Text] [Related]
39. Interactions between HIV-1 Vif and human ElonginB-ElonginC are important for CBF-β binding to Vif.
Wang X; Wang X; Zhang H; Lv M; Zuo T; Wu H; Wang J; Liu D; Wang C; Zhang J; Li X; Wu J; Yu B; Kong W; Yu X
Retrovirology; 2013 Aug; 10():94. PubMed ID: 23988114
[TBL] [Abstract][Full Text] [Related]
40. APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.
Batisse J; Guerrero SX; Bernacchi S; Richert L; Godet J; Goldschmidt V; Mély Y; Marquet R; de Rocquigny H; Paillart JC
J Virol; 2013 Jun; 87(11):6492-506. PubMed ID: 23576497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
